Pitfalls in immunohistochemical validation of tumor marker expression — Exemplified in invasive cancer of the uterine cervix
Data up to Jan 2025
Total Citations Per Year
Abstract
References (40)
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 • 2,891 citations
The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells
2007 • 985 citations
FIGO staging classifications and clinical practice gudelines in the management of gynecologic cancers
2000 • 871 citations
Cytokeratins 20 and 7 as biomarkers
2002 • 282 citations
Differential Expression of E-Cadherin in Lobular and Ductal Neoplasms of the Breast and Its Biologic and Diagnostic Implications
2001 • 277 citations
Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease
2005 • 275 citations
Overexpression of the αvβ6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival
2007 • 170 citations
Increased Cyclooxygenase-2 Expression Is Associated With Chemotherapy Resistance and Poor Survival in Cervical Cancer Patients
2002 • 159 citations
Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy
2003 • 127 citations
CD25<sup>+</sup>CD4<sup>+</sup> Regulatory T-Cells in Cancer
2005 • 112 citations
Aberrant Cell Cycle Regulation in Cervical Carcinoma
2005 • 99 citations
The p53 story: layers of complexity
2005 • 92 citations
Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis
2003 • 83 citations
c-Myc, Genome Instability, and Tumorigenesis: The Devil Is in the Details
2006 • 81 citations
LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking
2007 • 78 citations
Mechanisms Leading to COX-2 Expression and COX-2 Induced Tumorigenesis: Topical Therapeutic Strategies Targeting COX-2 Expression and Activity
2006 • 72 citations
Increased Cyclooxygenase-2 Expression Is Associated With Chemotherapy Resistance and Poor Survival in Cervical Cancer Patients
2002 • 72 citations
Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma
2001 • 71 citations
Prognostic relevance of TGF‐β1 and PAI‐1 in cervical cancer
2004 • 63 citations
Correlation between the tumoral expression of β3-integrin and outcome in cervical cancer patients who had undergone radiotherapy
2004 • 61 citations
Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study
2005 • 54 citations
Evaluation of p53 and Bcl-2 Expression as Prognostic Markers in Invasive Cervical Carcinoma Stage IIb/III Patients Treated by Radiotherapy
2002 • 41 citations
Utility of Proliferation-Associated Marker MIB-1 in Evaluating Lesions of the Uterine Cervix
1999 • 40 citations
Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease
2005 • 35 citations
Cyclins and proliferation markers in early squamous cervical carcinoma
2004 • 33 citations
CD44 family and gynaecological cancer.
2004 • 31 citations
Pd-ECGF positivity correlates with better survival, while iNOS has no predictive value for cervical carcinomas treated with radiotherapy
2003 • 26 citations
Cyclooxygenase-2 and Epidermal Growth Factor Receptor Expressions in Different Histological Subtypes of Cervical Carcinomas
2007 • 25 citations
Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expressions.
2007 • 20 citations
Loss of MSH2 protein expression is a risk factor in early stage cervical cancer
2007 • 19 citations
P53 expression as a predictor of recurrence in cervical squamous cell carcinoma
2002 • 18 citations
c-Myc protein expression is not an independent prognostic predictor in cervical squamous cell carcinoma
2002 • 17 citations
C-myc oncoprotein expression and prognosis in patients with carcinoma of the cervix: an immunohistochemical study.
2002 • 17 citations
P16-Immunostaining Pattern as a Predictive Marker of Lymph Node Metastasis and Recurrence in Early Uterine Cervical Cancer
2006 • 13 citations
CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB.
2005 • 11 citations
Hormones and progeny of breast tumor cells
2006 • 11 citations
Correlation p53 expression and human papilloma virus deoxyribonucleic acid with clinical outcome in early uterine cervical carcinoma
2005 • 9 citations
Cervical squamous cell carcinoma
2009 • 8 citations
Expression of thymidine phosphorylase as an effect prediction factor for uterine cervical squamous cell carcinoma after radiotherapy: an immunohistochemical study
2006 • 5 citations
Markers of apoptosis in stage IB squamous cervical carcinoma
2005 • 5 citations